VLDL
|
Basic information |
| Metabolite name | VLDL |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | very low-density lipoprotein; |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | VLDL |
| N/A |
|
N/A |
|
N/A |
| Synonyms | very low-density lipoprotein; |
| No. of studies | 6 |
|
Relationship between VLDL and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M021 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M035 | Type1 | depressed suicide attempters group vs. control group | Plasma | Human | Up |
| Study M051 | Type3 | fluoxetine group vs. control group | Astrocyte | Sprague-Dawley rat | Up |
| Study M066 | Type2 | CUMS + middle dose of YHTA group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M066 | Type2 | CUMS + venlafaxine group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M066 | Type2 | CUMS + low dose of YHTA group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M114 | Type3 | venlafaxine group vs. control group | Astrocyte | Sprague-Dawley rat | Down |
| Study M591 | Type1 | LPS group vs. control group | Plasma | CD-1 mouse | Down |